Revenue | ₹47.54Cr |
Net Profits | ₹2.67Cr |
Net Profit Margins | 5.62% |
Medicamen Biotech Ltd’s revenue jumped 5.57% since last year same period to ₹47.54Cr in the Q2 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated 9.24% jump in its revenue since last 3-months.
Medicamen Biotech Ltd’s net profit jumped 82.88% since last year same period to ₹2.67Cr in the Q2 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated 24.19% jump in its net profits since last 3-months.
Medicamen Biotech Ltd’s net profit margin jumped 73.22% since last year same period to 5.62% in the Q2 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated 13.68% jumped in its net profit margins since last 3-months.
The revenue for Medicamen Biotech Ltd in the Q2 results 2025 was ₹47.54Cr.
The net profit for Medicamen Biotech Ltd in the Q2 results 2025 was ₹2.67Cr.
The net profit margin for Medicamen Biotech Ltd in the Q2 results 2025 was 5.62%.
The revenue for Medicamen Biotech Ltd in the Q2 results 2024 was ₹45.03Cr.
The net profit for Medicamen Biotech Ltd in the Q2 results 2024 was ₹1.46Cr.
The net profit margin for Medicamen Biotech Ltd in the Q2 results 2024 was 3.24%.